Rare bilateral optic neuritis following herpes zoster ophthalmicus in an immunocompetent adult: A case report Authors: Mohammad Amin Najafi, Hamidreza Kianersi, Shamim Shafieioun, Maryam Soleimani Shokooh, Farshad Afshar Published: 2026 ABSTRACT AbstractBackgroundHerpes zoster ophthalmicus is caused by reactivation of varicella-zoster virus in the ophthalmic division of the trigeminal nerve. Optic neuritis is an uncommon but vision-threatening complication, and bilateral optic nerve involvement in immunocompetent individuals is exceptionally rare.Case presentationA 40-year-old immunocompetent man presented with acute right frontal and periorbital pain followed by a vesicular rash in the right ophthalmic division, including Hutchinson’s sign. Initial visual acuity was normal, and oral valacyclovir was started. Within days, he developed rapidly progressive visual loss in the right eye with optic disc edema and right optic nerve enhancement on orbital magnetic resonance imaging. Cerebrospinal fluid analysis and systemic autoimmune and infectious workups were unrevealing. After admission, oral valacyclovir was switched to intravenous acyclovir, and oral corticosteroid therapy was initiated. On the following day, visual acuity in the right eye declined to light perception, and the previously unaffected left eye developed decreased visual acuity, impaired color vision, and visual field defects. Corticosteroid treatment was therefore escalated to intravenous methylprednisolone pulse therapy. Because of subsequent bilateral visual deterioration, intravenous immunoglobulin was added and administered for 5 days. Despite partial radiologic improvement, vision in the right eye progressed to permanent no light perception. Left eye visual acuity partially recovered to 0.9 (approximately 20/22 Snellen) at follow-up.ConclusionThis case highlights the fulminant course of herpes zoster ophthalmicus-associated optic neuritis and shows that bilateral optic nerve involvement may occur even in immunocompetent patients. Early recognition, close monitoring of both eyes, and prompt escalation of therapy are critical when optic nerve involvement is suspected.Keywords: Herpes zoster Ophthalmicus (HZO), Herpes zoster, Acute retrobulbar optic neuritis (ON) Introduction Herpes zoster ophthalmicus (HZO) results from reactivation of latent varicella-zoster virus (VZV) in the trigeminal ganglion, with subsequent spread along the ophthalmic division of the trigeminal nerve (V1). HZO accounts for approximately 10–20% of all herpes zoster cases [1] and carries significant ophthalmological morbidity, including keratitis, uveitis, and, in severe cases, involvement of cranial nerves [2], optic neuropathy, acute retinal necrosis, progressive outer retinal necrosis [3]. VZV-associated optic neuritis is a rare but recognized complication of HZO, Proposed mechanisms include direct viral invasion of the optic nerve, immune-mediated inflammation or demyelination, and ischemic injury secondary to VZV-associated vasculopathy [2,4,5]. Bilateral optic neuritis in the context of HZO is particularly rare, especially in immunocompetent individuals [6]. Here, we report a 40-year-old immunocompetent man with HZO who developed rapidly progressive bilateral optic neuritis, resulting in permanent complete visual loss in the initially affected eye despite aggressive multimodal therapy, with partial recovery of vision in the subsequently affected eye. Case presentation A 40-year-old immunocompetent man, employed as an accountant, with no significant past medical history, presented with acute right-sided frontal and periorbital pain. On the following day, he developed a vesicular skin rash in the ophthalmic division of the trigeminal nerve (V1), involving the right forehead, upper eyelid, and tip of the nose, consistent with Hutchinson’s sign and suggestive of nasociliary branch involvement. There was no involvement of the maxillary division (V2). The patient reported no history of alcohol consumption. On day 2 after pain onset, the patient was evaluated by a dermatologist and was subsequently referred to an ophthalmology clinic. At that time, visual acuity was 1.0 (20/20 Snellen) in both eyes. Apart from grouped vesicular lesions in the right V1 distribution, anterior and posterior segment examinations were unremarkable bilaterally. Based on the diagnosis of herpes zoster ophthalmicus, oral valacyclovir 1000 mg every 8 h was initiated. On day 4, the patient developed blurred vision in the right eye and returned for ophthalmologic evaluation. Ophthalmologic examination revealed that visual acuity in the right eye had declined to hand motion. Corneal sensation was symmetric between the two eyes. A relative afferent pupillary defect was present in the right eye, and funduscopic examination revealed right optic disc edema. The left eye remained clinically normal. Optical coherence tomography (OCT) of both eyes was performed (Fig. 1). OCT of the right eye demonstrated mild optic disc edema with preservation of the physiological optic cup and mild peripapillary retinal nerve fiber layer (RNFL) thickening, with an average RNFL thickness of 114 µm. OCT findings in the left eye were within normal limits. Retinal Nerve Fiber Layer Optical Coherence Tomography (RNFL OCT) demonstrated mild right optic disc edema with an average RNFL thickness of 114 µm. OCT findings in the left eye were within normal limits. The patient was admitted to the neuro-ophthalmology service for further evaluation and treatment. Oral valacyclovir was discontinued, and intravenous acyclovir was initiated at 10 mg/kg every 8 h. Oral prednisolone 50 mg daily was also started. Brain and orbital magnetic resonance imaging (MRI) with gadolinium demonstrated right optic nerve enhancement with associated right frontal pachymeningeal thickening and enhancement along the frontal convexity, suggesting intracranial extension of the orbital inflammatory process (Fig. 2). MRI axial FLAIR (a and c) and T1 with contrast images (b and d): Right side intra-orbital fat stranding with thickening, enhancement and increased signal intensity of ipsilateral optic nerve as well as its sheath are noted. Also, orbital rectus muscles also enlarged and shows increased enhancement and thickening (blue arrows). Focal patchy meningeal thickening and enhancement along right frontal convexity probably due to intracranial extension of the orbital infection through cavernous sinus is seen (orange arrows). Lumbar puncture showed an essentially unremarkable cerebrospinal fluid profile, with 0 white blood cells/µL, 0 red blood cells/µL, protein of 48 mg/dL, and glucose of 67 mg/dL. Cerebrospinal fluid smear and culture were negative. Oligoclonal bands were absent, and the IgG index was within the normal range. Routine laboratory investigations, including complete blood count, erythrocyte sedimentation rate, C-reactive protein, renal and hepatic function tests, autoimmune testing for anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies, and infectious testing for tuberculosis, Lyme disease, HIV, hepatitis C virus, and hepatitis B virus, were unremarkable or negative. Sinus imaging showed no evidence of sinusitis. Serum vitamin B12 and folate levels were within the normal reference ranges. On day 7, visual acuity in the right eye further declined to light perception. On the same day, the patient developed blurred vision in the previously unaffected left eye, with visual acuity decreasing to 0.7 (approximately 20/30 Snellen). Repeat ophthalmologic examination showed more pronounced optic disc edema in the right eye, whereas the left eye showed no anterior or posterior segment abnormality other than reduced visual acuity. Color vision, assessed using the Ishihara 14-plate test, was markedly impaired in the left eye and was not evaluable in the right eye because of severe visual loss. Humphrey visual field testing using the SITA-Standard 24–2 strategy showed mild enlargement of the blind spot in the left eye, with an inferior cecocentral scotoma respecting the horizontal meridian and a mean deviation of −7.73 dB (Fig. 3a). Perimetry of the left eye showed mild enlargement of the blind spot with an inferior cecocentral scotoma respecting the horizontal meridian, with a mean deviation of −7.73 dB [3a]. At follow-up on day 25, Repeat perimetry of the left eye showed significant improvement compared with the previous visual field examination with a mean deviation of −0.29 dB [3b]. Given the rapid progression of right optic neuropathy and new contralateral visual involvement despite intravenous acyclovir and oral corticosteroid therapy, oral corticosteroid treatment was escalated to intravenous methylprednisolone pulse therapy at 1 g daily for 5 days. OCT-angiography of the optic nerve head was also performed at this stage. It demonstrated reduced radial peripapillary capillary density in the right eye, while the left eye showed preserved optic nerve head morphology, RNFL thickness, and retinal vascular plexuses. Repeat OCT also showed interval worsening of right optic disc edema compared with the previous imaging study (Fig. 4). Key RNFL OCT and OCT-angiography findings are summarized in Table 1. Optical Coherence Tomography Angiography (OCTA) demonstrated reduced radial peripapillary capillary density in the right eye. In contrast, the left eye showed intact retinal vascular plexuses. OCT-A RPC Density – Whole Image (%) (small vessels / all vessels) 46.0 / 54.6 in right eye and 51.7/57.8 in left eye. OCT-A Peripapillary RPC Density (%) 51.0 / 59.1 in right eye and 54.1/60.6 in left eye. Table 1Retinal nerve fiber layer optical coherence tomography (RNFL OCT) and Angiography (OCTA) parameters.ParameterRight Eye (OD)Left Eye (OS)Average RNFL thickness (µm)134108Superior RNFL thickness (µm)119109Inferior RNFL thickness (µm)148108Intra Eye (superior-inferior)-291Cup/Disc Area Ratio0.120.51Cup/Disc vertical Area Ratio0.220.64Cup/Disc horizontal Area Ratio0.340.86Disc Area (mm²)2.672.27Rim Area (mm²)2.261.12Cup Volume (mm3)0.0190.226Optic disc appearanceEdematousnormalOCT-A RPC Density – Whole Image (%) (small vessels / all vessels)50.5 / 58.751.7/57.8OCT-A RPC Density – Inside Disc(%) (small vessels / all vessels)53.4 / 64.349 / 57.3OCT-A Peripapillary RPC Density (%)56.6 / 64.454.1/60.6Macular OCT-A scan quality3/10 (NLP; poor fixation)9/10 (good)Macular vessel density (superficial)Markedly reducedPreservedRNFL: retinal nerve fiber layer; RPC: radial peripapillary capillary; OCT-A: optical coherence tomography angiography; NLP: no light perception. Retinal nerve fiber layer optical coherence tomography (RNFL OCT) and Angiography (OCTA) parameters. RNFL: retinal nerve fiber layer; RPC: radial peripapillary capillary; OCT-A: optical coherence tomography angiography; NLP: no light perception. On day 9, visual acuity in the right eye deteriorated to no light perception, while visual acuity in the left eye declined to 0.5 (20/40 Snellen). Because of continued bilateral visual deterioration despite antiviral therapy and escalation to intravenous corticosteroid treatment, intravenous immunoglobulin was added. Intravenous immunoglobulin was administered at a total dose of 2 g/kg, given as 150 g over 5 days. Follow-up MRI, performed after the onset of visual symptoms in the left eye, showed complete resolution of the previously noted right frontal pachymeningeal enhancement, with partial improvement of right optic nerve enhancement and optic nerve sheath thickening compared with the initial MRI (Fig. 5). follow up imaging after 9 days MRI axial FLAIR (a, c) and T1 with contrast images (b, d): decreased intra-orbital fat stranding and enhancement of rectus muscle and optic nerve sheath (a, b). Also, complete resolvent of right frontal convexity pachymeningeal enhancement (c, d). Despite combined antiviral, corticosteroid, and intravenous immunoglobulin therapy, there was no recovery of vision in the right eye. On day 12, visual acuity remained no light perception in the right eye, while visual acuity in the left eye worsened to 0.2 (20/100 Snellen). By day 15, at the completion of intravenous immunoglobulin therapy, visual acuity in the right eye remained no light perception, whereas visual acuity in the left eye improved to 0.5 (20/40 Snellen). After completion of intravenous methylprednisolone, oral prednisolone was continued for one week and was then tapered by 5 mg per day until discontinuation. On day 17, visual acuity remained no light perception in the right eye, while visual acuity in the left eye improved to 0.7 (approximately 20/30 Snellen). The patient was discharged on oral valacyclovir 1000 mg every 8 h for 1 additional week and tapering oral prednisolone. At follow-up on day 25, visual acuity in the right eye remained no light perception. Visual acuity in the left eye had improved to 0.9 (approximately 20/22 Snellen), although color vision remained impaired. Repeat perimetry of the left eye showed significant improvement compared with the previous visual field examination (Fig. 3b). Fig. 6 summarizes the disease course with the major events. Timeline of events. Discussion Optic neuritis is an uncommon but potentially devastating manifestation of HZO [5]. The present case is notable because a previously healthy immunocompetent adult developed rapidly progressive varicella-zoster virus (VZV)-associated optic neuritis, leading to irreversible visual loss in the initially affected eye and subsequent involvement of the contralateral eye. The clinical course was unusually fulminant. The patient initially developed right frontal and periorbital pain, followed by a vesicular V1 rash with Hutchinson’s sign. Although visual acuity was initially normal, right-sided visual loss developed shortly afterward and progressed rapidly from hand motion to light perception and then to no light perception within a few days. This severe trajectory emphasizes that new visual symptoms in patients with HZO, particularly in the presence of Hutchinson’s sign [7], should prompt urgent neuro-ophthalmologic evaluation and early treatment escalation. The mechanism of optic nerve involvement in HZO remains incompletely understood. Proposed mechanisms include direct viral spread from trigeminal pathways to adjacent neural structures, contiguous inflammatory extension through the orbital apex or cavernous sinus, immune-mediated demyelination triggered by VZV infection, and VZV-related vasculitic or ischemic injury to the optic nerve [8,9]. In our patient, initial MRI demonstrated right optic nerve enhancement together with right frontal pachymeningeal thickening and enhancement, suggesting that the inflammatory process extended beyond the ocular surface and may have involved adjacent intracranial pathways. The essentially normal cerebrospinal fluid profile did not exclude VZV-associated optic neuropathy, particularly given the characteristic clinical presentation and supportive MRI findings. The development of visual symptoms in the left eye further highlights the atypical severity of this case. Bilateral optic nerve involvement after unilateral HZO is rare [6], especially in an immunocompetent host. The left eye had normal anterior and posterior segment examinations, but visual acuity and color vision declined during the acute phase, suggesting functional involvement of the contralateral optic pathway, possibly at a retrobulbar stage. The negative anti-aquaporin-4 and anti-MOG antibodies, together with negative infectious testing and absence of sinusitis, made alternative causes of atypical optic neuritis less likely and supported VZV-associated optic neuritis as the most plausible diagnosis. OCT and OCT-angiography provided useful structural correlates of disease severity. Initial OCT showed mild right optic disc edema, which subsequently progressed on repeat imaging. OCT-angiography demonstrated reduced radial peripapillary capillary density in the right eye, a finding that may reflect severe inflammatory swelling, impaired peripapillary perfusion, or microvascular compromise. These findings were consistent with the profound visual loss in the right eye. In contrast, the preserved optic nerve head morphology, RNFL thickness, and retinal vascular plexuses in the left eye may partly explain the partial visual recovery observed clinically. Follow-up MRI showed resolution of the right frontal pachymeningeal enhancement and partial improvement of right optic nerve enhancement and sheath thickening. However, this radiologic improvement did not translate into visual recovery in the right eye, suggesting that irreversible axonal injury had already occurred. This discrepancy is clinically important, as improvement in enhancement does not necessarily indicate functional recovery. There is no standardized treatment protocol for VZV-associated optic neuritis [9]. Severe neuro-ophthalmic involvement is generally treated with intravenous acyclovir, often combined with systemic corticosteroids. In this case, treatment was escalated to intravenous acyclovir and high-dose intravenous methylprednisolone, and IVIG was later added after contralateral visual involvement. Although left eye vision partially recovered after multimodal therapy, causality cannot be established from a single case. Conclusion This case illustrates a fulminant course of HZO-associated optic neuritis, resulting in irreversible unilateral blindness with subsequent contralateral visual involvement in an immunocompetent adult. The findings underscore the importance of close bilateral monitoring, urgent neuroimaging, and prompt escalation of antiviral and anti-inflammatory treatment when optic nerve involvement is suspected in patients with HZO. Authors’ contributions Mohammad Amin Najafi, Hamidreza Kianersi, Shamim Shafieioun, Maryam Soleimani Shokooh and Farshad Afshar wrote the main manuscript text and Farshad Afshar prepared figures and table. CRediT authorship contribution statement Mohammad Amin Najafi: Writing – original draft. Hamidreza Kianersi: Writing – original draft. Shamim Shafieioun: Writing – original draft. Maryam Soleimani Shokooh: Writing – original draft. Farshad Afshar: Writing – original draft. Ethics declaration Written informed consent to take part in the study and to publish the article has been obtained from all participants or their legal representatives. The privacy rights of participants have been observed. This study was performed in compliance with relevant laws, regulatory frameworks and guidelines where the research took place. This study was approved by the Institutional Review Board of Isfahan University of Medical Sciences. (Approval No. 0) This research follows the CARE guidelines and the CARE checklist. Ethics approval and consent to participate The research adhered to the ethical standards outlined in the Helsinki Declaration and obtained approval from the Institutional Review Board of Isfahan University of Medical Sciences. Consent for publication Written informed consent was obtained from the patient for the publication of their medical information, clinical details, and radiologic/imaging findings related to this case. The patient was informed that all efforts would be made to protect their identity and confidentiality, and that no identifying personal information would be disclosed. Declaration of Generative AI and AI-assisted technologies in the writing process During the preparation of this work, the author(s) used Chatgpt AI for text editing. The author(s) reviewed and edited the output as needed and take full responsibility for the content of the published article. Funding No funding. Declaration of Competing Interest The authors declare no competing interests. Acknowledgements The authors of this article are extremely grateful to Isfahan Eye Research Center for their great help in preparing this article. Data availability No datasets were generated or analysed during the current study. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.